International Society for Cell & Gene Therapy Conference 2025.


CEO Jason C. Foster will be speaking on two panels and presenting how IRO® is setting the new standard for CGT manufacturing in the global showcase. The Ori team will also be showcasing live IRO demos and presenting new data.

New Orleans

May 7 - 10, 2025


Ori Biotech will be attending the International Society for Cell & Gene Therapy Annual Conference in New Orleans.

ISCT is the largest global cell and gene therapy conference with over 3000 delegates.

Here’s where you can find us:

Wednesday, May 7, 2025 | 12:00–13:00

Room MR 217-219

Panel session on ‘How Next Generation Technologies and Services are Enabling Widespread Patient Access to Cell and Gene Therapies’.

Jason C. Foster, CEO Oribiotech, Moderator
Jenny Stjernberg, PhD Sr. Director of Global Sales and Business Development, Cell and Gene Therapy Technologies, Fresenius Kabi
Ali Soleymannezhad, Chief Commercial Officer, MaxCyte
Taby Ahsan, PhD VP Cell and Gene Therapy Operations, City of Hope
Nandhu Mohan Sobhana, PhD, VP Head of Cell Engineering and Product Design, Volnay Therapeutics

Wednesday, May 7, 2025 | 16:00–18:00

Level 2, Room MR 223

Join us for refreshments and networking with the Ori team to talk about IRO®, solving manufacturing bottlenecks, and increasing patient access to cell therapies.

Thursday, May 8, 2025 | 10:30–10:45

Global Showcase Theater A

Accelerating Product Development.

Learn all about how Oribiotech’s IRO Platform is setting the new standard for CGT manufacturing by accelerating product development and returning the flexibility to innovate to expert scientists, where it belongs.

Friday May 9, 2025 | 16:15–17:15

Room MR 217-219

Panel session on ‘CGT Industry Trends: Using Market and Financing Insights to Avoid Commercial Failure’.

Jason C. Foster, CEO Oribiotech, Chair
Ingrid Gafanhao, Healthcare Analyst, Redwheel Life Changing Treatments Fund, Chair
Sanjay Srivastava, Managing Director, Accenture
Joe Thorne, Managing Director, Senior Biotechnology Equity Research Analyst, TD Cowen Inc.
Angela Vollstedt, Director, Global R&D Cell & Gene Therapies Portfolio, Novartis

Integrate IRO® - Sign Up for a Demo at ISCT

See the latest demo experience and discover how IRO seamlessly integrates with your manufacturing process while cutting tech transfer time, reducing manufacturing by 1-2 days, and accelerating product development.

  • See new IRO data presentation
  • Meet the team of IRO experts + Customer Support
  • Have 1:1 private meeting on your manufacturing process needs

Share this page